Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Open Access
- 25 February 1993
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 328 (8) , 527-532
- https://doi.org/10.1056/nejm199302253280802
Abstract
The frequency of infection with multidrug-resistant Mycobacterium tuberculosis is increasing. We reviewed the clinical courses of 171 patients with pulmonary disease due to M. tuberculosis resistant to rifampin and isoniazid who were referred to our hospital between 1973 and 1983. The patients' records were analyzed retrospectively. Their regimens were selected individually and preferably included three medications that they had not been given previously and to which the strain was fully susceptible.Keywords
This publication has 19 references indexed in Scilit:
- Qualitative and Quantitative Drug-susceptibility Tests in MycobacteriologyAmerican Review of Respiratory Disease, 1988
- Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosisTubercle, 1988
- From the AuthorAmerican Review of Respiratory Disease, 1983
- A Continuing Study of Primary Drug-resistant Tuberculosis Among Children Observed at the Kings County Hospital Medical Center Between the Years 1961 and 1980American Review of Respiratory Disease, 1983
- Whither short-course chemotherapy?Respiratory Medicine, 1981
- TRANSMISSION OF MULTIPLE DRUG-RESISTANT TUBERCULOSIS: REPORT OF A SCHOOL AND COMMUNITY OUTBREAKAmerican Journal of Epidemiology, 1981
- The Antituberculosis Efficacy of Rifampin in 136 PatientsChest, 1972
- Treatment of drug-resistant tuberculosisDisease-a-Month, 1971
- Rifampin in the Treatment of Drug-ResistantMycobacterium tuberculosisInfectionsNew England Journal of Medicine, 1970
- Ethionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosisTubercle, 1962